Advanced search
Companies (1)
ANNEXIN PHARMACEUTICALS AB
Annexin Pharmaceuticals AB (publ) is a Sweden-based biotechnology company. Its main product is ANXV, a human recombinant protein Annexin A5, for emergency treatment of patients with cardiovascular disease with blood vessel damages and inflammation. ANXV h ...
| Capitalization | 9 M USD |
|---|---|
| Change | -3.69% |
| 1-year price change | +0.38% |
- Stock Market
- Advanced search
- Mikael Dolsten
- Company Profiles
